A new study has identified a promising drug target for a common chronic illness that could shield insulin-producing cells ...

The latest Chinese drug developer to turn to the capital markets is Hangzhou Sciwind Biosciences Co. Ltd., which is working ...

Biomea Fusion shares spiked on positive 52-week Phase II data for icovamenib in type 2 diabetes. Read why I rate BMEA stock a ...

Background： Sepsis is a complex clinical syndrome characterized by dysregulated immune responses, systemic inflammation, and ...

MINNEAPOLIS, MN—Fewer than one-quarter of patients who have heart failure with reduced ejection (HFrEF) and no clinical ...

Sanofi raised its interest in AlphaMedix when it bought a 16% stake in Orano Med, a subsidiary of French nuclear fuel company ...

RJVA-002 achieved ~30% weight loss at five weeks in a translational obesity model; weight loss not yet plateauedPreclinical ...

Shattuck Labs, Inc. ( NASDAQ: STTK) The United European Gastroenterology (UEG) Congress UEG Week 2025 October 8, 2025 10:00 AM EDT ...

Eccogene receives US FDA clearance to initiate phase 2a MOSAIC trial of ECC4703 & ECC0509 for MASH: Boston, Massachusetts Tuesday, October 7, 2025, 15:00 Hrs [IST] Eccogene, a cli ...

The way you cook your food alters the compounds your body is consuming — and certain ones play a role in accelerated aging.

From bispecific engineering to clinically relevant data sourcing, evolving antibody technologies advance oncology therapeutics.